1)八尾恒良.Crohn病診断基準(案).厚生省特定疾患難治性炎症性腸管障害調査研究班.平成6年度業績集,pp 63-66, 1995
2)Hanauer SB. Top-down versus step-up approaches to chronic inflammatory bowel disease : presumed innocent or presumed guilty. Nat Clin Pract Gastroenterol Hepatol 2 : 493, 2005
3)Rutgeerts P, Diamond RH, Bala M, et al. Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease. Gastrointest Endosc 63 : 433-442, 2006
4)八尾恒良,櫻井俊弘,松井敏幸,他.アフタ様病変のみのCrohn病─典型的Crohn病との差異とその経過.胃と腸 29 : 507-519, 1994
5)Matsumoto T, Iida M, Nakamura S, et al. Crohn's disease of aphthous type : serial changes in intestinal lesions. Br J Radiol 73 : 1046-1051, 2000
6)平井郁仁,矢野豊,大原次郎,他.アフタ様病変のみから成るCrohn病の長期経過.胃と腸 40 : 895- 910, 2005
7)岩男泰,杉野吉則,井上詠,他.非定型的Crohn病の診断と経過─内視鏡所見を中心に.胃と腸 41 : 925-938, 2006
8)Papadakis KA, Prehn J, Moreno ST, et al. CCR9-positive lymphocytes and thymus-expressed chemoミkine distinguish small bowel from colonic Crohn's disease. Gastroenterology 121 : 246-254, 2001
9)Saruta M, Yu QT, Avanesyan A, et al. Phenotype and effector function of CC chemokine receptor 9-expressing lymphocytes in small intestinal Crohn's disease. J Immunol 178 : 3293-3300, 2007